---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-017218"
form_type: "8-K"
ticker: "RMD"
cik: "0000943819"
company_name: "RESMED INC"
filed_at: "2025-01-30T23:59:59+00:00"
generated_at: "2026-05-27T06:17:52.781356+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ResMed reports Q2 FY2025 revenue up 10% to $1.28B; non-GAAP EPS $2.43, up 29%

## Summary
- Revenue $1.28B (+10% YoY); gross margin 58.6% (+300 bps) on manufacturing efficiencies.
- Non-GAAP diluted EPS $2.43 (+29%); operating income $417M (+52% vs $275M, prior year had $64M restructuring).
- Operating cash flow $309M; paid $78M dividends and repurchased $75M shares during quarter.
- Board declared $0.53 quarterly dividend; record Feb 13, 2025, payable Mar 20, 2025.
- Residential Care Software revenue up 8% constant currency; U.S./Canada/Latin America revenue up 12%.

## SEC filing metadata
- accession: 0001193125-25-017218
- form_type: 8-K
- ticker: RMD
- cik: 0000943819
- company_name: RESMED INC
- filed_at: 2025-01-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/943819/000119312525017218/0001193125-25-017218-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/943819/000119312525017218/d888970d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-017218
- JSON: https://secwatch.observer/filing/0001193125-25-017218.json
- Plain text: https://secwatch.observer/filing/0001193125-25-017218.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.